|
Sex
| | |
0.852
|
|
Male
|
55 (79.7%)
|
47 (81.0%)
| |
|
Female
|
16 (20.3%)
|
11 (19.0%)
| |
|
Age, median (range)
|
11.8 (3.8–18.9)
|
12.2 (4.5–25.1)
|
0.606
|
|
Initial presentation
|
|
Headache
|
35 (50.7%)
|
35 (60.3%)
|
0.278
|
|
Vomiting
|
28 (40.6%)
|
28 (48.3%)
|
0.384
|
|
Endocrine problems
|
21 (30.4%)
|
18 (31.0%)
|
0.942
|
|
Visual problems
|
19 (27.9%)
|
19 (32.8%)
|
0.557
|
|
Neurologic symptoms
|
20 (29.0%)
|
14 (24.1%)
|
0.539
|
|
Tumor location
| | |
0.223
|
|
Pineal
|
24 (34.8%)
|
28 (47.5%)
| |
|
Sellar or suprasellar
|
14 (20.3%)
|
13 (22.0%)
| |
|
Thalamus or basal ganglia
|
17 (24.6%)
|
7 (11.9%)
| |
|
Ventricle
|
1 (1.4%)
|
1 (1.7%)
| |
|
Bifocal
|
10 (14.5%)
|
7 (11.9%)
| |
|
Multifocal
|
3 (4.3%)
|
1 (1.7%)
| |
|
Brain stem
|
0 (0.0%)
|
1 (1.7%)
| |
|
Pathologic diagnosis
| | |
< 0.001
|
|
Germinoma
|
66 (95.7%)
|
14 (23.7%)
| |
|
Immature teratoma
|
0 (0.0%)
|
5 (8.5%)
| |
|
Choriocarcinoma
|
0 (0.0%)
|
1 (1.7%)
| |
|
Mixed
|
0 (0.0%)
|
14 (23.7%)
| |
|
Unknown
|
3 (4.3%)
|
24 (40.7%)
| |
|
Tumor seeding on MRI, Yes
|
7 (10.1%)
|
7 (12.3%)
|
0.704
|
|
Initial hydrocephalus, Yes
|
39 (56.5%)
|
30 (51.7%)
|
0.589
|
|
ETV, Yes
|
28 (40.6%)
|
23 (39.7%)
|
0.916
|
|
EVD, Yes
|
24 (34.8%)
|
14 (24.1%)
|
0.192
|
|
Initial EVD and subsequent VP shunt insertion, Yes
|
5 (7.2%)
|
6 (10.3%)
|
0.536
|
|
Direct VP shunt insertion, Yes
|
5 (7.2%)
|
4 (6.9%)
|
0.939
|
|
Operation due to growing teratoma, Yes
|
2 (2.9%)
|
12 (20.7%)
|
0.001
|
|
Follow-up year, median (range)
|
8.4 (0.3–14.1)
|
8.3 (0.2–14.2)
|
0.706
|
